Home > Healthcare > Pharmaceuticals > Finished Drug Form > Growth Hormone Market

Growth Hormone Market Share

  • Report ID: GMI5042
  • Published Date: Jul 2023
  • Report Format: PDF

Growth Hormone Market Share

  • Novo Nordisk A/S
  • Novartis AG
  • Merck KGaA
  • Anhui Anke Biotechnology (Group) Co., Ltd
  • Pfizer Inc
  • Eli Lily And Company
  • Ipsen S.A.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Growth hormone industry was valued at over USD 3.3 billion in 2022 and will grow at more than 6% CAGR from 2023 to 2032, attributed to the rising prevalence of growth hormone deficiency globally.

The growth hormone powder segment size will reach over USD 3.9 billion by 2032, owing to its ease of storage, cost-effectiveness, and long shelf life.

North America growth hormone market amassed over 43% revenue share in 2022 on account of huge investment in R&D activities for the development of innovative growth hormone medications in the region.

Major growth hormone industry players include Novo Nordisk A/S, Novartis AG, Merck KGaA, Ipsen S.A., Pfizer Inc., Eli Lily And Company, and Anhui Anke Biotechnology (Group) Co., Ltd, among others.

Growth Hormone Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 220
  • Countries covered: 12
  • Pages: 160
 Download Free Sample